Cargando…
Apparent Triclabendazole-Resistant Human Fasciola hepatica Infection, the Netherlands
Autores principales: | Winkelhagen, Annemarie J.S., Mank, Theo, de Vries, Peter J., Soetekouw, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358177/ https://www.ncbi.nlm.nih.gov/pubmed/22607719 http://dx.doi.org/10.3201/eid1806.120302 |
Ejemplares similares
-
Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle()
por: Brockwell, Yvette M., et al.
Publicado: (2013) -
A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance
por: Beesley, Nicola J., et al.
Publicado: (2023) -
Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica
por: Davis, Chelsea N., et al.
Publicado: (2020) -
Triclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro
por: SHRIFI, Yosef, et al.
Publicado: (2014) -
Pilot Evaluation of Two Fasciola hepatica Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics
por: Collett, Clare F., et al.
Publicado: (2020)